Novavax, Inc. (NASDAQ:NVAX) went down by -3.26% from its latest closing price when compared to the 1-year high value of $61.50 and move down -37.31%, while NVAX stocks collected -15.20% of loss with the last five trading sessions. Press Release reported 8 hours ago that Novavax President of R&D Dr. Gregory Glenn to Discuss the Development of COVID-19 Vaccines on Panel at 2020 BIO Digital
Novavax, Inc. (NASDAQ:NVAX) Worth an Investment?
Novavax, Inc. (NASDAQ: NVAX) The 36 Months beta value for NVAX stocks is at 1.40, while of the analysts out of 0 who provided ratings for Novavax, Inc. stocks as a “buy” while as overweight, rated it as hold and as sell. The average price we get from analysts is $50.83 which is $4.41 above current price. NVAX currently has a short float of 13.17% and public float of 55.90M with average trading volume of 9.74M shares.
NVAX Market Performance
NVAX stocks went down by -15.20% for the week, with the monthly jump of 146.78% and a quarterly performance of 347.01%, while its annual performance rate touched 631.86%. The simple moving average for the period of the last 20 days is 0.91% for NVAX stocks with the simple moving average of 283.85% for the last 200 days.
Analysts’ Opinion on Novavax, Inc. (NASDAQ:NVAX)
Many brokerage firms have already submitted their reports for NVAX stocks, with JP Morgan repeating the rating for NVAX shares by setting it to “Neutral”. The predicted price for NVAX socks in the upcoming period according to JP Morgan is $46 based on the research report published on June 5, 2020.
B. Riley FBR, on the other hand, stated in their research note that they expect to see NVAX stock at the price of $61, previously predicting the value of $53. The rating they have provided for NVAX stocks is “Buy” according to the report published on May 28, 2020.
H.C. Wainwright gave “Buy” rating to NVAX stocks, setting the target price at $50 in the report published on May 12, 2020.
NVAX Stocks 58.39% Far from 50 Day Moving Average
After a stumble in the market that brought NVAX to its low price for the period of the last 52 weeks, Novavax, Inc. was unable to take a rebound, for now settling with -27.17% of loss for the given period.
The stock volatility was left at 14.18%, however, within the period of a single month, the volatility rate increased by 11.92%, while the shares surge at the distance of +139.14% for the moving average in the last 20 days. In oppose to the moving average for the last 50 days, trading by +251.57% upper at the present time.
In the course of the last 5 trading sessions, NVAX went down by -15.20%, which changed the moving average for the period of 200 days to the total of +555.78% of gains for the stock in comparison to the 20-day moving average settled at $45.69. In addition, Novavax, Inc. saw 1025.38% in overturn over the period of a single year with a tendency to cut further gains.
NVAX Stock Insider Trading
Reports are indicating that there were more than several insider trading activities at Novavax, Inc. (NVAX), starting from YOUNG JAMES F, who bought 1,500 shares at the price of $48.83 back on Jun 03. After this action, Rushing now owns 1,500 shares of Novavax, Inc., valued at $73,245 with the latest closing price.
Herrmann John A III, the SVP, General Counsel of Novavax, Inc., sold 12,961 shares at the value of $49.44 during a trade that took place back on May 18, which means that Herrmann John A III is holding 275 shares at the value of $640,792 based on the most recent closing price.
NVAX Stock Fundamentals
The current profitability levels are settled at -694.44 for the present operating margin. The net margin for Novavax, Inc. stands at -711.04. Total capital return value is set at -87.24, while invested capital returns managed to touch -89.70. Equity return holds the value 78.80%, with -53.90% for asset returns.
The value for Enterprise to Sales is 153.89 with debt to enterprise value settled at 0.96. The receivables turnover for Novavax, Inc. is 4.98 with the total asset turnover at the value of 0.10. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.77.